These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33538159)

  • 1. Chemical Highlights Supporting the Role of Lipid A in Efficient Biological Adaptation of Gram-Negative Bacteria to External Stresses.
    Troudi A; Pagès JM; Brunel JM
    J Med Chem; 2021 Feb; 64(4):1816-1834. PubMed ID: 33538159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of membrane targeting antibiotics.
    Epand RM; Walker C; Epand RF; Magarvey NA
    Biochim Biophys Acta; 2016 May; 1858(5):980-7. PubMed ID: 26514603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid a biosynthesis of multidrug-resistant pathogens - a novel drug target.
    Lee CR; Lee JH; Jeong BC; Lee SH
    Curr Pharm Des; 2013; 19(36):6534-50. PubMed ID: 23829374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis, transport, and modification of lipid A.
    Trent MS
    Biochem Cell Biol; 2004 Feb; 82(1):71-86. PubMed ID: 15052329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Agents That Inhibit the Outer Membrane Assembly Machines of Gram-Negative Bacteria.
    Choi U; Lee CR
    J Microbiol Biotechnol; 2019 Jan; 29(1):1-10. PubMed ID: 29996592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are outer-membrane targets the solution for MDR Gram-negative bacteria?
    Walker SS; Black TA
    Drug Discov Today; 2021 Sep; 26(9):2152-2158. PubMed ID: 33798647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery strategies to outer membrane targets in Gram-negative pathogens.
    Brown DG
    Bioorg Med Chem; 2016 Dec; 24(24):6320-6331. PubMed ID: 27178386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria.
    Yethon JA; Whitfield C
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):91-106. PubMed ID: 12455407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, inhibition, and regulation of essential lipid A enzymes.
    Zhou P; Zhao J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1424-1438. PubMed ID: 27940308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.
    Giordano NP; Cian MB; Dalebroux ZD
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32253250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the lipid bilayer in outer membrane protein folding in Gram-negative bacteria.
    Horne JE; Brockwell DJ; Radford SE
    J Biol Chem; 2020 Jul; 295(30):10340-10367. PubMed ID: 32499369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unravelling the mechanisms of the biogenesis of the outer membrane of Gram-negative bacteria: a step toward the development of new antibiotics].
    Collet JF
    Bull Mem Acad R Med Belg; 2009; 164(7-9):213-20; discussion 220. PubMed ID: 20218188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence-based methods to assay inhibitors of lipopolysaccharide synthesis.
    Hernick M
    Methods Mol Biol; 2011; 739():123-33. PubMed ID: 21567323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria.
    Liu F; Ma S
    Mini Rev Med Chem; 2018; 18(4):310-323. PubMed ID: 27739357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodelling of the Gram-negative bacterial Kdo
    Valvano MA
    Microbiology (Reading); 2022 Apr; 168(4):. PubMed ID: 35394417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid A modification systems in gram-negative bacteria.
    Raetz CR; Reynolds CM; Trent MS; Bishop RE
    Annu Rev Biochem; 2007; 76():295-329. PubMed ID: 17362200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical Impact of Lipid A Modification Caused by Mobile Colistin Resistance Gene on Bacterial Outer Membranes.
    Ma W; Jiang X; Dou Y; Zhang Z; Li J; Yuan B; Yang K
    J Phys Chem Lett; 2021 Dec; 12(48):11629-11635. PubMed ID: 34817187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria.
    Chen J; Li X; Li L; Zhang T; Zhang Q; Wu F; Wang D; Hu H; Tian C; Liao D; Zhao L; Song D; Zhao Y; Wu C; Song X
    Cell Res; 2019 Sep; 29(9):711-724. PubMed ID: 31399697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.